China approves second Coronavirus vaccine CoronaVac

▴ China approves second Coronavirus vaccine CoronaVac
Sinovac's Coronavac jab is the second vaccine to be approved by Chinese authorities

China's drug authorities have given "conditional" approval for a second Covid-19 vaccine, Sinovac's CoronaVac jab, the pharmaceutical company said Saturday.

The vaccine has already been rolled out to key groups at higher risk of exposure to coronavirus but Saturday's approval allows for its use on the general public.

A conditional approval helps hustle emergency drugs to market in cases when clinical trials are yet to meet normal standards but indicate therapies will work.

The approval comes after multiple domestic and overseas trials of the vaccine in countries including Brazil and Turkey, although "efficacy and safety results need to be further confirmed", Sinovac said in a statement.

Fellow Chinese pharmaceutical company Sinopharm received a similar conditional green light in December to put its vaccine on the market.

Sinovac said trials in Brazil had shown around 50 per cent efficacy in preventing infection and 80 percent efficacy in preventing cases requiring medical intervention.

"The results show that the vaccine has good safety and immunogenic effect on people of all age groups," Sinovac said Saturday.

Meanwhile, Sinopharm said in December that its vaccine had a 79.34 per cent efficacy rate, lower than rival jabs developed in the West by Pfizer-BioNTech and Moderna -- with 95 and 94 per cent rates respectively.

China has been racing to develop homegrown jabs and aims to vaccinate 50 million people before the start of the Lunar New Year in mid-February.

The holiday normally spurs a travel rush with hundreds of millions traversing the country -- though authorities are encouraging people to stay home this year through a mixture of restrictions and incentives.

As China ramps up its vaccine campaign, authorities have repeatedly assured the public of the jab's safety and efficacy, despite not releasing any detailed clinical trial data.

At the same time, Beijing has been promoting its vaccines abroad in what analysts have called "vaccine diplomacy" to earn goodwill after facing criticism for its early handling of the outbreak.

China's foreign ministry on Wednesday said it planned to provide 10 million vaccine doses to the WHO-backed international vaccine distribution programme Covax.

Beijing has also pledged to share the vaccine at a fair cost -- a potential boost for poorer Asian countries who are otherwise reliant on limited distribution offered by the Covax scheme.

Countries including Senegal, Indonesia, and Hungary have procured millions of vaccine doses from Chinese pharmaceutical firms.

But take-up has been slower abroad for Chinese vaccines compared to jabs from Pfizer-BioNTech and Moderna, as little information has been published about the safety or efficacy of Chinese vaccines.

Chinese vaccine makers also have chequered reputations, after major scandals at home involving expired or poor quality products.

Story Courtesy

www.indiatoday.com 

AFP

Tags : #Coronavac #Sinovac #CoronavacJab #ChineseVaccines #ChinaVaccineNews #Beijing #Covaxin #Covax #VaccineDiplomacy #WHO

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Murder in the Name of God: Kashmir and the Collapse of HumanityApril 24, 2025
6 Early Warning Signs of Malaria You Shouldn’t IgnoreApril 24, 2025
World Meningitis Day: A Loud Alarm for a Quiet KillerApril 24, 2025
Amid Documented Progress, India’s Malaria-Free Dream Faces Ground Realities.April 24, 2025
Medanta Surgeons Remove Rare Tumour, Rebuild Face of Iraqi Toddler in 14-Hour Surgery.April 24, 2025
Burnett Homeopathy Hosts Historic World Homeopathy Summit 3 During World Homeopathy Week in Germany April 24, 2025
Mind Over Meltdown: The Underrated Skill Saving Relationships and SanityApril 23, 2025
Moscow Accelerates AI Testing in Healthcare with New Diagnostic MethodApril 23, 2025
The Weight Loss Drug That Could Weigh Down Your Mind: A Closer Look at Ozempic’s Hidden CostApril 23, 2025
The Chaos That Makes You Human: How Disorder in the Brain Creates Order in ThoughtApril 23, 2025
Benefiting 7,000 Children Across 30 Schools with CSR InitiativesApril 23, 2025
MGM Healthcare Performs Life-Saving Surgery on 6-Year-Old Boy with Severe Heart BlockageApril 23, 2025
5 Ways Rheumatic Diseases Affect Women DifferentlyApril 23, 2025
Centrum launches Centrum Recharge Energy Drink Mix with Brand Ambassador Anushka SharmaApril 23, 2025
Hair Fall Is No Longer a Headache – A New Non-Surgical Super Treatment Is Here”April 23, 2025
Herbalife India Launches Sleep EnhanceTM April 23, 2025
Sharda Care Healthcity Successfully Removes Massive 16.5 kg Ovarian Tumour in High-Risk PatientApril 23, 2025
Lighthouse Canton White Paper Projects 3,200 Single-Family Offices in Asia Pacific by 2030 April 22, 2025
CSK Players Meet “Let’s READ” beneficiaries with FedEx CaresApril 22, 2025
Atherosclerosis: The Hidden Threat to Your HeartApril 22, 2025